Scleroderma, Diffuse - 20 Studies Found
Completed |
: High Dose Intravenous N-Acetylcysteine Versus Iloprost for Early, Rapidly Progressive Diffuse Systemic Sclerosis : Scleroderma, Diffuse : 2007-01-29 : Drug: N-acetylcysteine (NAC) |
Recruiting |
: Proof-of-concept Trial of IVA337 in Diffuse Cutaneous Systemic Sclerosis :
|
Recruiting |
: Scleroderma Registry & Repository at the Hospital for Special Surgery : Scleroderma : 2012-08-01 |
Terminated |
: Thalidomide for Decreasing Collagen Biosynthesis in People With Progressive Systemic Sclerosis : Scleroderma, Systemic : 2007-01-03 :
|
Completed |
: Nilotinib in the Treatment of Systemic Sclerosis : Systemic Sclerosis : 2010-07-01 : Drug: Nilotinib (Tasigna) Patients will be treated with Nilotinib 400 mg two times a day for 6 months. |
Active, not recruiting |
: Taking Charge of Systemic Sclerosis : Scleroderma : 2015-05-22 :
|
Completed |
: Morbidity and Mortality Follow Up for the Scleroderma Lung Study : Scleroderma : 2013-01-04 : Other: Followup survey |
Completed |
: Imatinib Mesylate (Gleevec) in the Treatment of Systemic Sclerosis : Systemic Sclerosis : 2007-11-07 : Drug: Imatinib Mesylate In initial phase, patients will be treated with Gleevec 400 mg daily for 12 mont |
Completed |
: Angiogenic/Angiostatic Mediators in Patients With Systemic Sclerosis : Systemic Sclerosis : 2008-04-25 |
Recruiting |
: Campath-1h Phase I/II Pilot Trial as Immunoablative Therapy for Refractory Systemic Sclerosis : Scleroderma : 2012-06-18 : Drug: Campath Pediatric patients with dcSSc are eligible for the clinical trial if they fulfill the incl |